VA agrees to reimburse activity-tracking device

The Department of Veterans Affairs has approved the StepWatch activity-tracking device and Orthocare Innovation's Europa for reimbursement under the agency's National Orthotic and Prosthetic Program. "We applaud VHA's efforts to lead the field by being the first to systematically collect functional data to help gain improved insight into the performance of veterans who utilize lower limb prosthetics. With StepWatch identified as the only activity tracker among a very crowded field that meets its requirements, Modus Health is committed to supporting veterans in the use of our technology to help improve the quality of its clinical care," said Modus Health CEO Doug McCormack. Release

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.